SANGUINE BIOSCIENCES OPENS NEW APHERESIS DONOR CENTER TO SUPPORT CELL & GENE THERAPY AND TRANSLATIONAL RESEARCH INITIATIVES
WALTHAM, Mass., Sept. 13, 2023 /PRNewswire/ -- Sanguine Biosciences ("Sanguine"), a leader in connecting patients with biomedical researchers to accelerate precision medicine R&D, today announced its opening of a blood donor center in Los Angeles, California. The center will specialize in collecting concentrated white blood cell biospecimens through apheresis (a.k.a. leukopaks) from participants in Sanguine's Patient Community network. These research products facilitate advanced therapy development programs from discovery to manufacturing.
- WALTHAM, Mass., Sept. 13, 2023 /PRNewswire/ -- Sanguine Biosciences ("Sanguine"), a leader in connecting patients with biomedical researchers to accelerate precision medicine R&D, today announced its opening of a blood donor center in Los Angeles, California.
- The center will specialize in collecting concentrated white blood cell biospecimens through apheresis (a.k.a.
- Furthermore, the leukopak specimen resembles the cell or gene therapy product that patients ultimately receive.
- Opening our first center of hopefully many enables Sanguine to achieve its mission of facilitating patient participation in the medical research process," said Sanguine Co-Founder and CEO Brian Neman.